Comparative safety analysis of baloxavir marboxil and oseltamivir based on the FAERS database

When using oseltamivir and baloxavir marboxil clinically, attention should be paid not only to common ADEs but also to those not mentioned on the drug label.

Authors

Institutions

Publication Details

Journal
Expert Opinion on Drug Safety
Published
2025-04-17
DOI
https://doi.org/10.1080/14740338.2025.2495854
Primary Topic
Drug-Induced Hepatotoxicity and Protection
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Comparative safety analysis of baloxavir marboxil and oseltamivir based on the FAERS database

Xin Lai, Qing Wan, Yingqiu Tu, Tiantian Xu
Expert Opinion on Drug Safety
Drug-Induced Hepatotoxicity and Protection
article

Comparative safety analysis of baloxavir marboxil and oseltamivir based on the FAERS database

Xin Lai, Qing Wan, Yingqiu Tu, Tiantian Xu
article en

Abstract

When using oseltamivir and baloxavir marboxil clinically, attention should be paid not only to common ADEs but also to those not mentioned on the drug label.

Expert Opinion on Drug SafetyVol. 25(2)
Nanchang University (CN), First Affiliated Hospital of Nanchang University (CN)
Openalex Percentile: Top 90%
Drug-Induced Hepatotoxicity and Protection
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Comparative safety analysis of baloxavir marboxil and oseltamivir based on the FAERS database — Xin Lai, Qing Wan, et al. · Expert Opinion on Drug Safety (2025) | TGRS Research Map | TGRS